Novartis Investigative Site

Meguro City, Tokyo 153-8515

0 studies enrolling now · 3 studies all time

What they study most

Ankylosing Spondylitis, Non-radiographic Spondyloarthritis, Systemic Lupus Erythematosus

Studies at this site

• Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) — Running, not enrolling
• Effect of Secukinumab on Radiographic Progression in Ankylosing Spondylitis as Compared to GP2017 (Adalimumab Biosimilar) — Completed
• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed